Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report)’s share price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 26.50 ($0.33) and traded as low as GBX 26 ($0.32). Mereo BioPharma Group plc (MPH.L) shares last traded at GBX 26.50 ($0.33), with a volume of 49,264 shares changing hands.
Mereo BioPharma Group plc (MPH.L) Stock Performance
The stock has a market cap of £89.76 million and a price-to-earnings ratio of -0.21. The company has a debt-to-equity ratio of 164.26, a quick ratio of 2.92 and a current ratio of 2.98. The company’s 50 day simple moving average is GBX 26.50 and its 200 day simple moving average is GBX 26.50.
Mereo BioPharma Group plc (MPH.L) Company Profile
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Further Reading
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- What is a Death Cross in Stocks?
- Comprehensive Analysis of PayPal Stock
- P/E Ratio Calculation: How to Assess Stocks
- Intuitive Surgical Stock Can Trend Much Higher This Year
- How to Invest in Biotech Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
